Effect of Sex and Age on HbA1c, Body Weight, and Systolic Blood Pressure Reduction with Dapagliflozin

被引：0
|
作者：
Reusch, Jane E. B.
Day, Danielle
Wortzman-Show, Genevieve
Katz, Arie
Regensteiner, Judith G.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1253-P
引用
收藏
页码：A325 / A325
页数：1
相关论文
共 50 条
  • [21] Discontinuation of Dapagliflozin in DEPICT-1 and DEPICT-2 Led to Clinically Meaningful Increases in HbA1c and Body Weight
    Gordon, Jason
    Danne, Thomas
    Beresford-Hulme, Lee M.
    Bennett, Hayley
    Tank, Amarjeet
    Edmonds, Christopher
    Thoren, Fredrik A.
    Scheerer, Markus F.
    McEwan, Philip
    DIABETES, 2019, 68
  • [22] Effect of dapagliflozin on HbA1c and weight after its addition to various combinations of other diabetes medications: ABCD nationwide dapagliflozin audit
    Yadagiri, M.
    Sen Gupta, P.
    Pang, T.
    Balmuri, L.
    Robinson, T.
    Bain, S.
    Gallen, I. W.
    Adamson, K.
    Ryder, R. E. J.
    DIABETOLOGIA, 2016, 59 : S338 - S338
  • [23] Dapagliflozin as Part of Triple Combination Therapy Helps Reduce HbA1c and Body Weight in Patients With Type 2 Diabetes
    Jabbour, Serge
    Hardy, Elise
    Debruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Rohwedder, Katja
    Martin, Paula
    Parikh, Shamik J.
    DIABETES, 2013, 62 : A306 - A307
  • [24] Arterial systolic and diastolic blood pressure are not associated with HbA1c levels but arterial systolic blood pressure alone associated with 1-h postchallenge glucose levels
    Kashima, Koji
    Okada, Kazuya
    Okada, Junichi
    Ohshima, Kihachi
    Okada, Shuichi
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (04) : 791 - 793
  • [25] Arterial systolic and diastolic blood pressure are not associated with HbA1c levels but arterial systolic blood pressure alone associated with 1-h postchallenge glucose levels
    Koji Kashima
    Kazuya Okada
    Junichi Okada
    Kihachi Ohshima
    Shuichi Okada
    International Journal of Diabetes in Developing Countries, 2022, 42 : 791 - 793
  • [26] Impact of the Integrated Care Pilot on HbA1c, cholesterol and systolic blood pressure levels in patients with diabetes
    Adomaviciute, S.
    Watt, H.
    Soljak, M.
    Car, J.
    Majeed, A.
    DIABETIC MEDICINE, 2014, 31 : 175 - 175
  • [27] The effect of liraglutide on HbA1c and body weight is largely independent of baseline diabetes duration
    Seufert, J. R.
    Bailey, T.
    Svendsen, C.
    Donsmark, M.
    Nauck, M. A.
    DIABETOLOGIA, 2013, 56 : S356 - S357
  • [28] Dapagliflozin Lowers HbA1c, Systolic Blood Pressure and Serum Uric Acid in Patients With Type 2 Diabetes and Hypertension, Regardless of Class of Concomitant Antihypertensive Therapy
    Weber, Michael A.
    Mansfield, Traci A.
    Iqbal, Nayyar
    Parikh, Shamik J.
    Ptaszynska, Agata
    CIRCULATION, 2014, 130
  • [29] Exenatide provides HbA1c reductions comparable to insulin with the additional effect of weight reduction
    Ivanyi, Tibor
    Kim, Dennis
    Brodows, Robert
    Trautmann, Michael
    Festa, Andreas
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S139 - S139
  • [30] Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
    Ertugrul, Derun Taner
    Kan, Erdal
    Tura, Cigdem Bahadir
    Tugtekin, Haci Bayram
    Ayakta, Hayati
    Celebioglu, Mehmet
    Yilmaz, Ceren
    Utebay, Onur
    Yetkin, Ilhan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (01) : 147 - 160
12345